Positive nuclear and cytoplasmic 2SC staining and a loss of FH staining via immunohistochemistry have been shown to be highly specific in identifying HLRCC‐associated renal tumors (Bardella et al., 2011; Chen et al., 2014; Trpkov et al., 2016). Here, FH is linked to hereditary leiomyomatosis and renal cell cancer.